cromakalim has been researched along with Arterial Occlusive Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffith, TM; Randall, MD | 1 |
| Angerbach, D; Nicholson, CD | 1 |
2 other study(ies) available for cromakalim and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Effects of BRL 38227, sodium nitroprusside and verapamil on collateral perfusion following acute arterial occlusion in the rabbit isolated ear.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Benzopyrans; Cromakalim; Ear, External; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Pyrroles; Rabbits; Regional Blood Flow; Vasodilation; Vasodilator Agents; Verapamil | 1992 |
Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease.
Topics: Animals; Antihypertensive Agents; Arterial Occlusive Diseases; Benzopyrans; Calcium Channel Blockers; Cell Membrane; Cromakalim; Hydralazine; In Vitro Techniques; Male; Muscles; Oxygen Consumption; Potassium; Pyrroles; Rats; Rats, Inbred Strains; Regional Blood Flow | 1988 |